ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

Exosomes as Drug Delivery Systems to Treat Cancer

Authors

DR. P. TRIPURA SUNDARI , D. VISHWANAYANI

Keywords

Exosome, Tumour, Carriers, Targeted drug delivery systems.

Abstract

Exosomes are intended for targeted drug delivery systems which are extracellular vesicles and are surrounded by phosholipid bilayers. These are similar to Nanoparticulate drug delivery systems but have various advantages, these are released by erythrocytes of multivesicular bodies. Exosomes are secreted by immune cells and are enclosed by a lipid bilayers and few cytosols which are devoid of any kind of cellular organelle. The method of loading exosomes is electroporation, incubation, and sonication which results in effective drug loading into the exosomes. Tumour derived exosomes can selectively enter the cancer cells and therefore act as a carrier for enhanced drug delivery to tumour cells.

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJRTI — journal style
"Exosomes as Drug Delivery Systems to Treat Cancer", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.5, Issue 3, page no.88 - 92, March-2020, Available :https://ijrti.org/papers/IJRTI2003015.pdf
APA — 7th edition
SUNDARI, P. T., & VISHWANAYANI, D. (2020). Exosomes as Drug Delivery Systems to Treat Cancer. International Journal for Research Trends and Innovation, 5(3), 88 - 92. https://ijrti.org/viewpaperforall.php?paper=IJRTI2003015
MLA — 9th edition
SUNDARI, P. TRIPURA, and D. VISHWANAYANI. "Exosomes as Drug Delivery Systems to Treat Cancer." International Journal for Research Trends and Innovation, vol. 5, no. 3, 2020, pp. 88 - 92, https://ijrti.org/viewpaperforall.php?paper=IJRTI2003015.
Chicago — 17th, bibliography
SUNDARI, P. TRIPURA, and D. VISHWANAYANI. "Exosomes as Drug Delivery Systems to Treat Cancer." International Journal for Research Trends and Innovation 5, no. 3 (2020): 88 - 92. https://ijrti.org/viewpaperforall.php?paper=IJRTI2003015.
Harvard — author–date
SUNDARI, P.T. and VISHWANAYANI, D. (2020) 'Exosomes as Drug Delivery Systems to Treat Cancer', International Journal for Research Trends and Innovation, 5(3), pp. 88 - 92. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2003015
IEEE — numbered reference
P. T. SUNDARI and D. VISHWANAYANI, "Exosomes as Drug Delivery Systems to Treat Cancer," IJRTI, vol. 5, no. 3, pp. 88 - 92, Mar. 2020.
Vancouver — biomedical
SUNDARI PT, VISHWANAYANI D. Exosomes as Drug Delivery Systems to Treat Cancer. IJRTI. 2020 Mar;5(3):88 - 92.
AMA — 11th edition
SUNDARI PT, VISHWANAYANI D. Exosomes as Drug Delivery Systems to Treat Cancer. IJRTI. 2020;5(3):88 - 92. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2003015
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2003015, author = {P. TRIPURA SUNDARI and D. VISHWANAYANI}, title = {Exosomes as Drug Delivery Systems to Treat Cancer}, journal = {International Journal for Research Trends and Innovation}, volume = {5}, number = {3}, pages = {88 - 92}, year = {2020}, month = {March}, issn = {2456-3315}, url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2003015} }
RIS — EndNote, RefWorks
TY - JOUR AU - SUNDARI, P. TRIPURA AU - VISHWANAYANI, D. TI - Exosomes as Drug Delivery Systems to Treat Cancer T2 - International Journal for Research Trends and Innovation JA - IJRTI VL - 5 IS - 3 PY - 2020 SN - 2456-3315 UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2003015 SP - 88 EP - 92 ER -

Issue

Volume 5 Issue 3, March-2020
Pages : 88 - 92

Other Publication Details

Paper Reg. ID IJRTI_181197
Published Paper ID IJRTI2003015
Downloads 205,630
Research Area Pharmacy
Country Bharkathpura, TELANGANA, India
Published March 2020

About Publisher

International Journal for Research Trends and Innovation Published by IJRTI (JW Publication)
2456-3315 ISSN
10.57 Impact Factor
2016 ESTD Year
Open Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.

Licence

© 2020 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹599
Publish in a UGC CARE Approved Journal | Low Cost ₹599 Indian Author | 🌐 $45 USD International
CrossRef/DataCite DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →